Drug Trial Radar · NCT00817414
A Study to Evaluate the Effects of LCI699 on Cortisol in Participants With Hypertension
Last checked: Nov 19, 2026Latest source record: Jun 2, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
63
Actual
Start
Jan 14, 2009
Primary completion
Aug 12, 2009
Study completion Aug 12, 2009
Sponsor
- Lead sponsor
- NovartisNovartis (NVS)
- Sponsor type
- Industry
- Collaborators
- Great Lakes Drug Development, Inc.; Integrium
- First posted
- Jan 6, 2009
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study determined the maximum dose of LCI6999 with respect to effect on the ACTH-stimulated cortisol response in participants with hypertension.
Conditions
- Hypertension
Interventions
LCI699-matching placeboDrug
LCI699-matching placebo oral capsules
LCI699Drug
LCI699 oral capsules
Primary outcomes
What the sponsor says the trial is designed to measure.
- Maximum Tolerated Dose (MTD) of LCI699 With Respect to Effect on the Adrenocorticotropic Hormone (ACTH)-Stimulated Cortisol Response Following ACTH Stimulation in Hypertensive ParticipantsTime frame: Up to Week 6
Locations
11 sites in 2 countries. Site status is shown where the registry gives one.
Impact Clinical Trials
Beverly Hills, California
Associated Pharmaceutical Research Center, Inc
Buena Park, California
Innovative Clinical Research, Inc
Harbor City, California
Long Beach Center for Clinical Research
Long Beach, California
Metro Clinical Research
Littleton, Colorado
Clinical Study Center of Asheville, LLC
Asheville, North Carolina
Northstate Clinical Research
Lenoir, North Carolina
Tipton Medical & Diagnostic Center
Tipton, Pennsylvania
Punzi Medical Center
Carrollton, Texas
dgd Research, Inc
San Antonio, Texas
Encode Clinic
Reykjavik, SA, Iceland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.